Etalanetug

N/A

Report date: 2025/09/17 18:02:16

Base Information

Drug NameEtalanetug
Drug Alias NameE2814E-2814
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunomodulatorsMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer DiseaseDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPuerto Rico +[16] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEisai Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseDementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A